Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) has embarked on a strategic awareness campaign aimed at preparing the market for the commercialization of its IzoView Breast CT Imaging System. This innovative medical device company, specializing in advanced breast cancer imaging, is leveraging targeted news updates, a podcast series, and a dedicated website, breastct.com, to...
Author: News Desk (News Desk)
Lantern Pharma Introduces AI Module to Enhance Cancer Combination Therapies Development
Lantern Pharma (NASDAQ: LTRN), a leader in AI-driven oncology drug development, has unveiled a novel AI-powered module designed to optimize the development of combination therapies for cancer treatment. This innovative tool, part of the company’s RADR(R) platform, specializes in predicting the effectiveness of therapies that combine DNA-damaging agents (DDAs) with DNA damage response inhibitors (DDRis)....
GrabAGun Digital Holdings Inc. to Begin Trading on NYSE Following Successful Business Combination
GrabAGun Digital Holdings Inc., formerly known as Metroplex Trading Company LLC, has successfully completed its business combination with Colombier Acquisition Corp. II, marking a significant milestone for the online firearms retailer. The combined entity is set to commence trading on the New York Stock Exchange under the ticker symbols ‘PEW’ and ‘PEWW’ starting July 16,...
Standard Lithium Ltd. Reports Record Lithium Grades at Smackover Project
Standard Lithium Ltd. (NYSE American: SLI), in collaboration with Equinor through their joint venture Smackover Lithium, has reported a significant achievement at their South West Arkansas (SWA) Project. Sampling from the Lester well has revealed the highest lithium concentration to date, reaching 616 mg/L, with an average of 582 mg/L across three samples. This development...
Former Democratic State Senator Jim Brochin Considers Independent Bid for Baltimore County Executive
Former State Senator Jim Brochin, who narrowly missed securing the Democratic nomination for Baltimore County Executive in 2018 by a mere 17 votes, is now exploring the possibility of entering the race as an independent candidate. Brochin, without delving into details during a brief text exchange, expressed his apprehension about the potential for unchecked development...
Baltimore’s Progress in Crime Reduction Faces Threat from Federal Cuts
Baltimore’s federal delegation recently highlighted the city’s progress in reducing crime rates, vacant properties, and overdose deaths, yet expressed concern over how federal actions could undermine these achievements. Mayor Brandon Scott reported a 22.7% decrease in homicides and a 19.6% decline in nonfatal shootings since last July, alongside reductions in auto thefts, robberies, arson, and...
Benzinga and Cboe to Host Free Webinar on the Future of Cryptocurrency
The cryptocurrency ecosystem continues to evolve at a rapid pace, prompting the need for informed discussions on its future direction. Benzinga, in partnership with Cboe Global Markets, is set to host a free webinar titled ‘Navigating the Evolving Cryptocurrency Landscape & Cboe’s Digital Asset Offerings’ on July 17 at 11:00 AM EST. This event aims...
Bluespring Wealth Partners Merger Unites Hickory Asset Management and Ritter Daniher Financial Advisory
The merger between Hickory Asset Management, Inc. and Ritter Daniher Financial Advisory LLC, both under the umbrella of Bluespring Wealth Partners, marks a significant consolidation in the wealth management sector, creating a combined entity with over $865 million in assets under management. This strategic move is set to enhance the firms’ ability to deliver personalized...
Shopoff Realty Investments Secures $52 Million Refinance for Mesa Development Project
Shopoff Realty Investments announced the securing of $52 million in financing from Peachtree Group for The Block at Elliot, a 270-acre undeveloped land project in Mesa, Arizona. This financial injection is earmarked for grading, offsite street, and utility improvements, propelling the project into its next development phase. William A. Shopoff, President and CEO of Shopoff...
Soligenix Inc. Anticipates Key Catalysts in 2025 for Rare Disease Treatments
Soligenix Inc. (NASDAQ: SNGX), a biopharmaceutical company specializing in rare diseases, has been highlighted in a recent Zacks Small-Cap Research report for its anticipated key catalysts in the latter half of 2025. The report underscores the company’s progress in its phase 3 FLASH2 trial of HyBryte(TM) for early-stage cutaneous T cell lymphoma (CTCL), with an...